Hugh Magen

Hugh leads the development of the reusable Controller and the system integration. Hugh has over 20 years in the medical device field. He has a broad range of experience, having developed implants for women’s health, cardiology, urology and orthopedics, as well as several energy delivery devices incorporating the modalities of RF energy, cryogen, and electromagnetics. Previously, Hugh was a consultant providing his expertise in research and design, project management, and company growth strategy to several early stage medical device start-ups. He was Sr. Director of R&D at Rubicor Medical, developing minimally invasive image-guided devices for breast cancer diagnosis and treatment procedures. At Stellartech Research Corporation, a provider of contract R&D and manufacturing services, Hugh was the lead engineer developing the Thermage Thermacool system. Additionally, Hugh held senior engineering roles at Coapt Systems and Vascular Therapies (US Surgical Corp [now Covidien]). Hugh received a BS in Aerospace Engineering from the University of Virginia and an MS in Biomedical Engineering from the University of California at Davis.

Important Safety Information:

The Mara Water Vapor Ablation System is indicated to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia due to benign causes for whom childbearing is complete. Pregnancy following the Mara procedure can be dangerous. The Mara procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Mara Water Vapor Ablation System. Please refer to the device labeling for a detailed discussion of the device’s intended use, relevant warnings, precautions, side effects, and contraindications.